化合物SB1317 hydrochloride T4227
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
5 mg | T4227 | ¥1,120.00 | 询底价 |
2 mg | T4227 | ¥622.00 | 询底价 |
25 mg | T4227 | ¥3,290.00 | 询底价 |
100 mg | T4227 | ¥6,560.00 | 询底价 |
1 mg | T4227 | ¥346.00 | 询底价 |
10 mg | T4227 | ¥1,830.00 | 询底价 |
1 mL | T4227 | ¥1,230.00 | 询底价 |
50 mg | T4227 | ¥4,000.00 | 询底价 |
Product Introduction
Bioactivity
英文名: SB1317 hydrochloride (1204918-72-8(free base))
描述: SB1317 hydrochloride (1204918-72-8(free base)) (TG-02 hydrochloride) 是一种有效的 CDK2/JAK2/FLT3 抑制剂(IC50:13/73/56 nM)。
体外活性: SB1317 (25 μM) has no inhibition of Human CYP1A2, 3A4, 2C9, and 2C19 isoforms, but has inhibition of CYP2D6 (IC50: 0.95 μM). SB1317 inhibits cell proliferation of HCT-116 (IC50: 0.079 μM) and HL-60 (IC50: 0.059 μM)[1]. SB1317 is mainly metabolized by CYP3A4 and CY1A2 in vitro. SB1317 does not inhibit any of the major human CYPs in vitro except CYP2D6 (IC50=1 μM). CYP1A and CYP3A4 are mainly expressed in human hepatocytes in vitro.
体内活性: SB1317 (75 mg/kg/day, p.o., 3×/week) markedly inhibits the growth of tumors with a mean TGI of 82%, while the lower dose (50 mg/kg/day, p.o., 3×/week) is marginally effective. Treatment with SB1317 using either regime significantly inhibits the growth of tumors with mean TGIs of 42% (p.o.) and 63% (i.p.), respectively[1]. In pharmacokinetic studies, SB1317 shows moderate to high systemic clearance (relative to liver blood flow), high volume of distribution (>0.6 L/kg), oral bioavailability of 24%, ~4 and 37% in mice, rats, and dogs, respectively; and extensive tissue distribution in mice.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 26.5 mg/mL
关键字: TG02 Hydrochloride | SB1317 hydrochloride (1204918-72-8(free base)) | SB1317 hydrochloride (1204918 72 8(free base)) | SB-1317 hydrochloride (1204918-72-8(free base)) | SB1317 hydrochloride (1204918728(free base)) | TG-02 Hydrochloride | TG 02 Hydrochloride
相关产品: Allitinib tosylate | Edicotinib | Crenolanib | FLT3-IN-10 | UNC2541 | Quizartinib | AZD2932 | Onatasertib | CHMFL-FLT3-122 | BMS-2
相关库: JAK-STAT Compound Library | Drug Repurposing Compound Library | Anti-Cancer Drug Library | Anti-Lung Cancer Compound Library | Anti-Cancer Clinical Compound Library | Kinase Inhibitor Library | Inhibitor Library | Anti-Cancer Active Compound Library | Tyrosine Kinase Inhibitor Library | Stem Cell Differentiation Compound Library
化合物SB1317 hydrochloride T4227信息由TargetMol中国为您提供,如您想了解更多关于化合物SB1317 hydrochloride T4227报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途